Charles Large

Charles Large

Company: Autifony Therapeutics

Job title: Chief Executive Officer

Seminars:

Live Q&A Session with Your Expert Speakers 4:30 pm

Read more

day: Day One

Precision Medicine with Kv3 Channel Modulators: Matching Mechanism to Patient Pathophysiology 3:00 pm

• Development of Kv3 channel modulators for the treatment of rare neurodevelopmental disorders, such as Fragile X Syndrome and genetic epilepsies • Matching the target and drug mechanism to the most appropriate patient populations • Selecting mechanism and disease-relevant biomarkers such as EEG, auditory evoked potentials, or TMSRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.